Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.
about
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesLeukocytes: The Double-Edged Sword in FibrosisEndothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosisA role for partial endothelial-mesenchymal transitions in angiogenesis?Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features.Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis.A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related FibrosisPathogenesis of Systemic Sclerosis.Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation.Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.Interleukin-1β mediates high glucose induced phenotypic transition in human aortic endothelial cells.Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesA vascular mechanistic approach to understanding Raynaud phenomenon.Vasculopathy in scleroderma.Endothelial Hey2 deletion reduces endothelial-to-mesenchymal transition and mitigates radiation proctitis in mice.Recent advances in animal models of systemic sclerosis.Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?Endothelial cell-specific activation of transforming growth factor-β signaling in mice induces cutaneous, visceral, and microvascular fibrosis.The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseasesAngiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis.Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study.TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.Recent advances in the treatment of skin involvement in systemic sclerosis.Potential role of the Jagged1/Notch1 signaling pathway in the endothelial-myofibroblast transition during BLM-induced pulmonary fibrosis.Elevated serum levels of soluble CD146 in patients with systemic sclerosis.Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.Right Ventricle Remodeling and Function in Scleroderma Patients.The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis.Morphine Induces Fibroblast Activation through Up-regulation of Connexin 43 Expression: Implication of Fibrosis in Wound Healing.A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic SclerosisThe Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy
P2860
Q26748338-D30DE7E9-AF20-4923-9F55-2853307210CAQ26777122-DD609C78-3A9D-4C46-91B5-7B94226C59BFQ26852572-7AEFB56A-992C-43AE-9CF2-85367F30C207Q26864897-CD335AD4-CD5D-42A9-88DE-A547696E38F5Q34389943-B29AC394-C3E4-459F-9A42-AA2BAD741665Q34485231-E0A4C9E4-A366-4CD2-B792-63D5F860F540Q35587696-A366FF4A-A5D4-4935-A584-629DA3E976AFQ35693212-DA4EA4D5-506E-4322-9B89-8FADF6468298Q36103216-3CB4722A-5C9C-4DB6-9EF8-71FD1CFE34DBQ36371453-D6AAA621-1D66-411E-844F-A620E7EE6772Q36654322-6B90A8D9-1714-4B17-996E-136DC700E44CQ37316247-334901C1-2BA5-42F3-9301-2DD78FA35AF7Q37381549-49DD577A-5E11-4572-8C9C-898B2221F2D6Q38299133-AA403510-13CD-4001-8144-8F3BAFDB1F94Q38543688-666BE483-F6DD-4B8D-A574-33E871EB102AQ38685352-B0710F11-A0C5-43F1-9983-0246F4363BBCQ38701983-9931E27B-3B7F-498F-A405-8FCAFFAF1AD7Q38710580-D852E495-E377-4158-97E2-39DA74BE970BQ38873978-73D14FE1-5C8D-4BE0-B2EA-D66011D8EF04Q39211384-49C1492C-20A3-46F0-B547-3F5D016A0412Q41169103-656CB4DF-1A47-4155-A899-180654EEB53CQ41980258-EEF131FB-5162-476F-94C0-F03ECE5A2501Q42369819-71979A80-696F-461F-AC91-95818FE2AA56Q44537770-0654A044-5050-42A6-BE67-86771EB6543FQ47111024-BB694BDA-A8B1-4D9B-978D-22D21E6D0D4BQ47991834-38367DAF-0C8F-4F66-8337-62DB638BED6DQ51140742-08EE2615-128A-4ADB-9EAD-833664BABC44Q51672074-537F5568-8A93-4C66-A2B6-7F67BB9C5ACFQ55153213-549CE12F-192A-4396-91CF-F710D5B2E279Q55402074-9F147EE1-4F47-4354-89D7-8C1F33026BDBQ55646697-ADE81997-05D2-4EB1-A21A-4D0A8D4663CCQ57072741-F27DBFF0-2604-4BD8-8A47-FCBF7DDC513DQ58705720-8CE4126B-8777-4794-B38E-5614CB17C1CF
P2860
Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of endothelial to mesench ...... rations in systemic sclerosis.
@en
Role of endothelial to mesench ...... rations in systemic sclerosis.
@nl
type
label
Role of endothelial to mesench ...... rations in systemic sclerosis.
@en
Role of endothelial to mesench ...... rations in systemic sclerosis.
@nl
prefLabel
Role of endothelial to mesench ...... rations in systemic sclerosis.
@en
Role of endothelial to mesench ...... rations in systemic sclerosis.
@nl
P2860
P356
P1433
P1476
Role of endothelial to mesench ...... rations in systemic sclerosis.
@en
P2093
Sergio A Jimenez
P2860
P304
P356
10.1155/2013/835948
P577
2013-09-23T00:00:00Z